(Total Views: 272)
Posted On: 11/06/2017 1:12:10 PM
Post# of 72446
Yeah, the stock price is the same as it was years ago, when the company didn't have any clinical trials going.
Now we have had successful clinical trials for 3 totally different drugs, some with multiple applications, and we are waiting on results from three of them -- those results coming out in the next few months.
It certainly is Leo's fault that the share price is low. After all, what did he do, except get all those clinical trials going, at a very, very low cost. What crappy management, to do that. It would have been so much better if he had gotten the company into a lot of debt, wouldn't it?
Now we have had successful clinical trials for 3 totally different drugs, some with multiple applications, and we are waiting on results from three of them -- those results coming out in the next few months.
It certainly is Leo's fault that the share price is low. After all, what did he do, except get all those clinical trials going, at a very, very low cost. What crappy management, to do that. It would have been so much better if he had gotten the company into a lot of debt, wouldn't it?
(2)
(0)
